Phase I trial of gemcitabine and vinorelbine in patients with refractory solid tumors: efficacy with minimal toxicity in a geriatric population

被引：0
|
作者：
Radice, P [1 ]
Koletsky, A [1 ]
Greenhawt, M [1 ]
Frankel, C [1 ]
Pearce, P [1 ]
Byrne, C [1 ]
Jahanzeb, M [1 ]
机构：
[1] Interctr Ctr Canc Res Grp, Palm Beach, FL USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [21] Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma
    Hutson, TE
    Ganapathi, R
    Elson, P
    Mekhail, T
    Olencki, T
    Budd, GT
    Bukowski, RM
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (03) : 277 - 284
  • [22] Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma
    Thomas E. Hutson
    Ram Ganapathi
    Paul Elson
    Tarek Mekhail
    Thomas Olencki
    G. Thomas Budd
    Ronald M. Bukowski
    Investigational New Drugs, 2004, 22 : 277 - 284
  • [23] Phase I trial of everolimus and gemcitabine for patients with solid tumors refractory to standard therapy and for a cohort of patients with cholangiocarcinoma/gallbladder cancer
    Costello, B. A.
    Qi, Y.
    Borad, M. J.
    Kim, G. P.
    Northfelt, D. W.
    Erlichman, C.
    Alberts, S. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors
    Piatek, Caroline I.
    Raja, Grace L.
    Ji, Lingyun
    Gitlitz, Barbara Jennifer
    Dorff, Tanya B.
    Quinn, David I.
    Hu, James
    El-Khoueiry, Anthony B.
    Pham, Huyen Q.
    Roman, Lynda
    Garcia, Agustin A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1227 - 1234
  • [25] Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors
    Caroline I. Piatek
    Grace L. Raja
    Lingyun Ji
    Barbara Jennifer Gitlitz
    Tanya B. Dorff
    David I. Quinn
    James Hu
    Anthony B. El-Khoueiry
    Huyen Q. Pham
    Lynda Roman
    Agustin A. Garcia
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1227 - 1234
  • [26] Phase I trial of gemcitabine and paclitaxel in advanced solid tumors
    Lim, N
    Lara, PN
    Lau, DHM
    Edelman, MJ
    Tanaka, M
    Al-Jazayrly, G
    Houston, J
    Lauder, I
    Gandara, DR
    CANCER INVESTIGATION, 2003, 21 (01) : 7 - 13
  • [27] Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors
    Ali, Yaqoob
    Lin, Yong
    Gharibo, Mecide M.
    Gounder, Murugesan K.
    Stein, Mark N.
    Lagattuta, Theodore F.
    Egorin, Merrill J.
    Rubin, Eric H.
    Poplin, Elizabeth A.
    CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5876 - 5882
  • [28] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [29] Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors
    Ryan, David P.
    Appleman, Leonard J.
    Lynch, Thomas
    Supko, Jeffrey G.
    Fidias, Panagiotis
    Clark, Jeffrey W.
    Fishman, Mayer
    Zhu, Andrew X.
    Enzinger, Peter C.
    Kashala, Oscar
    Cusack, James, Jr.
    Eder, Joseph P.
    CANCER, 2006, 107 (10) : 2482 - 2489
  • [30] Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors
    Duran, I
    Siu, LL
    Chen, EX
    Oza, AM
    Sturgeon, J
    Chin, SF
    Brown, S
    Pond, GR
    Nottage, M
    ANTI-CANCER DRUGS, 2006, 17 (01) : 81 - 87
12345